To the extent possible under law, AOP-Wiki has waived all copyright and related or neighboring rights to KE:105

Event: 105

Key Event Title

The KE title should describe a discrete biological change that can be measured. It should generally define the biological object or process being measured and whether it is increased, decreased, or otherwise definably altered relative to a control state. For example “enzyme activity, decreased”, “hormone concentration, increased”, or “growth rate, decreased”, where the specific enzyme or hormone being measured is defined. More help

Inhibition, Mitochondrial Electron Transport Chain Complexes

Short name
The KE short name should be a reasonable abbreviation of the KE title and is used in labelling this object throughout the AOP-Wiki. The short name should be less than 80 characters in length. More help
Inhibition, ECT complexes of the respiratory chain

Biological Context

Structured terms, selected from a drop-down menu, are used to identify the level of biological organization for each KE. Note, KEs should be defined within a particular level of biological organization. Only KERs should be used to transition from one level of organization to another. Selection of the level of biological organization defines which structured terms will be available to select when defining the Event Components (below). More help
Level of Biological Organization

Cell term

Further information on Event Components and Biological Context may be viewed on the attached pdf.The biological context describes the location/biological environment in which the event takes place.  For molecular/cellular events this would include the cellular context (if known), organ context, and species/life stage/sex for which the event is relevant. For tissue/organ events cellular context is not applicable.  For individual/population events, the organ context is not applicable. More help

Organ term

Further information on Event Components and Biological Context may be viewed on the attached pdf.The biological context describes the location/biological environment in which the event takes place.  For molecular/cellular events this would include the cellular context (if known), organ context, and species/life stage/sex for which the event is relevant. For tissue/organ events cellular context is not applicable.  For individual/population events, the organ context is not applicable. More help

Key Event Components

Further information on Event Components and Biological Context may be viewed on the attached pdf.Because one of the aims of the AOP-KB is to facilitate de facto construction of AOP networks through the use of shared KE and KER elements, authors are also asked to define their KEs using a set of structured ontology terms (Event Components). In the absence of structured terms, the same KE can readily be defined using a number of synonymous titles (read by a computer as character strings). In order to make these synonymous KEs more machine-readable, KEs should also be defined by one or more “event components” consisting of a biological process, object, and action with each term originating from one of 22 biological ontologies (Ives, et al., 2017; See List). Biological process describes dynamics of the underlying biological system (e.g., receptor signalling). The biological object is the subject of the perturbation (e.g., a specific biological receptor that is activated or inhibited). Action represents the direction of perturbation of this system (generally increased or decreased; e.g., ‘decreased’ in the case of a receptor that is inhibited to indicate a decrease in the signalling by that receptor).Note that when editing Event Components, clicking an existing Event Component from the Suggestions menu will autopopulate these fields, along with their source ID and description. To clear any fields before submitting the event component, use the 'Clear process,' 'Clear object,' or 'Clear action' buttons. If a desired term does not exist, a new term request may be made via Term Requests. Event components may not be edited; to edit an event component, remove the existing event component and create a new one using the terms that you wish to add. More help

Key Event Overview

AOPs Including This Key Event

All of the AOPs that are linked to this KE will automatically be listed in this subsection. This table can be particularly useful for derivation of AOP networks including the KE. Clicking on the name of the AOP will bring you to the individual page for that AOP. More help
AOP Name Role of event in AOP Point of Contact Author Status OECD Status
Inhibition of Mt-ETC complexes leading to kidney toxicity MolecularInitiatingEvent Agnes Aggy (send email) Under development: Not open for comment. Do not cite
Kidney failure induced by inhibition of mitochondrial ETC KeyEvent Brendan Ferreri-Hanberry (send email) Under development: Not open for comment. Do not cite


This is a structured field used to identify specific agents (generally chemicals) that can trigger the KE. Stressors identified in this field will be linked to the KE in a machine-readable manner, such that, for example, a stressor search would identify this as an event the stressor can trigger. NOTE: intermediate or downstream KEs in one AOP may function as MIEs in other AOPs, meaning that stressor information may be added to the KE description, even if it is a downstream KE in the pathway currently under development.Information concerning the stressors that may trigger an MIE can be defined using a combination of structured and unstructured (free-text) fields. For example, structured fields may be used to indicate specific chemicals for which there is evidence of an interaction relevant to this MIE. By linking the KE description to a structured chemical name, it will be increasingly possible to link the MIE to other sources of chemical data and information, enhancing searchability and inter-operability among different data-sources and knowledgebases. The free-text section “Evidence for perturbation of this MIE by stressor” can be used both to identify the supporting evidence for specific stressors triggering the MIE as well as to define broad chemical categories or other properties that classify the stressors able to trigger the MIE for which specific structured terms may not exist. More help

Taxonomic Applicability

Latin or common names of a species or broader taxonomic grouping (e.g., class, order, family) can be selected from an ontology. In many cases, individual species identified in these structured fields will be those for which the strongest evidence used in constructing the AOP was available in relation to this KE. More help

Life Stages

The structured ontology terms for life-stage are more comprehensive than those for taxa, but may still require further description/development and explanation in the free text section. More help

Sex Applicability

The authors must select from one of the following: Male, female, mixed, asexual, third gender, hermaphrodite, or unspecific. More help

Key Event Description

A description of the biological state being observed or measured, the biological compartment in which it is measured, and its general role in the biology should be provided. For example, the biological state being measured could be the activity of an enzyme, the expression of a gene or abundance of an mRNA transcript, the concentration of a hormone or protein, neuronal activity, heart rate, etc. The biological compartment may be a particular cell type, tissue, organ, fluid (e.g., plasma, cerebrospinal fluid), etc. The role in the biology could describe the reaction that an enzyme catalyses and the role of that reaction within a given metabolic pathway; the protein that a gene or mRNA transcript codes for and the function of that protein; the function of a hormone in a given target tissue, physiological function of an organ, etc. Careful attention should be taken to avoid reference to other KEs, KERs or AOPs. Only describe this KE as a single isolated measurable event/state. This will ensure that the KE is modular and can be used by other AOPs, thereby facilitating construction of AOP networks. More help

The electron transport chain, otherwise known as the respiratory chain, is composed of large protein complexes (CI, CII, CIII, CIV, CV) and two freely mobile electron transfer carriers, ubiquinone and cytochrome c, which are embedded in the inner membrane cristae of the mitochondria (Zhao et al., 2019). Three of these complexes (CI, CIII, CIV; NADH dehydrogenase, cytochrome c reductase, and cytochrome c oxidase, respectively) act as proton pumps and contribute to the formation of an electrochemical proton gradient across the inner mitochondrial membrane, which then drives ATP synthesis by complex V (ATP synthase) (Alberts et al., 2014). In eukaryotes, the electron transport chain is the major site of ATP production via oxidative phosphorylation. Superoxides (O2) are generated in low quantities as by-products of oxidative phosphorylation during electron transfer. The O2 released into the inter-membrane space (IMS) by CIII can be converted into H2O2 in a reaction catalyzed by superoxide dismutase 1 and H2O2 then may diffuse into the cytoplasm (Zhao et al., 2019). Superoxides behave as signalling molecules important in cell proliferation, hypoxia adaption, and cell fate determination but when present in excess or unregulated, induce cell damage and death.

While it is well known that heavy metals target the mitochondria, the exact mechanism of this targeting and inhibition is poorly understood (Belyaeva et al., 2012; Gobe & Crane, 2010). Respiratory complexes CI and CIII are shown to be particularly susceptible to perturbation by heavy metals such as chromium and cadmium (Adiele et al., 2012; Santos et al., 2007). In addition, Uranyl Acetate (UA) induced nephrotoxicity has been linked to the impairment of CII and CIII leading to inhibition of the mitochondrial electron transport chain (Shaki et al., 2012; Shaki & Pourahmad, 2013).

Several studies have been conducted in order to understand the exact mechanisms of inhibition by heavy metals. They show that these divalent cations bind to electron transport chain enzyme complexes and modify them, disturbing electron transfer and redox reactions (Blajszczak & Bonini, 2017). For example, rotenone blocks Complex I (Li et al., 2003) and cadmium has the capability to noncompetitively inhibit CIII (Wang et al., 2004). This blocking and inhibition interrupts the transport of electrons through the respiratory chain, specifically resulting in the increase of semiubiquinone formation and subsequently the generation of mitochondrial superoxides (Li et al., 2003). Shaki et al. (2012) have shown, as well, that uranyl acetate (UA) interferes with CII and CIII activity. Function of the electron transport chain can also be suppressed by indirect effects of heavy metals: cisplatin causes oxidative damage of mitochondrial membrane lipids such as cardiolipin, impacting mitochondrial membrane potential (MMP). This lipid is responsible for maintaining the inner mitochondrial membrane structure and linking CIII and CIV in a super complex through which protons and electrons move, producing ATP (Santos et al., 2007). Cardiolipin function is therefore vital and its disruption results in inhibition of  mitochondrial integrity and function.

The inhibition of the electron transport chain initiates a sequence of events in the mitochondria, including: overproduction of reactive oxygen species (ROS); a reduced ability for oxidative phosphorylation and therefore decreased ATP synthesis; a lowered ATP/ADP ratio; the release of cytochrome c from the mitochondrial cristae; and the collapse of mitochondrial membrane potential (MMP) (Shaki et al., 2012; Adiele et al., 2012). All of these occurrences contribute to overall mitochondrial dysfunction and more adverse outcomes.

How It Is Measured or Detected

One of the primary considerations in evaluating AOPs is the relevance and reliability of the methods with which the KEs can be measured. The aim of this section of the KE description is not to provide detailed protocols, but rather to capture, in a sentence or two, per method, the type(s) of measurements that can be employed to evaluate the KE and the relative level of scientific confidence in those measurements. Methods that can be used to detect or measure the biological state represented in the KE should be briefly described and/or cited. These can range from citation of specific validated test guidelines, citation of specific methods published in the peer reviewed literature, or outlines of a general protocol or approach (e.g., a protein may be measured by ELISA).Key considerations regarding scientific confidence in the measurement approach include whether the assay is fit for purpose, whether it provides a direct or indirect measure of the biological state in question, whether it is repeatable and reproducible, and the extent to which it is accepted in the scientific and/or regulatory community. Information can be obtained from the OECD Test Guidelines website and the EURL ECVAM Database Service on Alternative Methods to Animal Experimentation (DB-ALM). ?
Assay Type & Measured Content Description Dose Range Studied

Assay Characteristics

(Length / Ease of use/Accuracy)

MTT assay

Measuring enzymatic activity of the electron transport system

(Thiebault et al., 2007; Shaki et al., 2012)

CII and CIII, transmembrane electrical potential change was measured.

The metabolic activity of mitochondrial complex II was assayed by measuring the reduction of MTT to a blue formazan compound. Mitochondrial suspensions were incubated with different concentrations of uranyl acetate prior to addition of MTT. The product of formazan crystals were dissolved in DMSO and the absorbance at 570nm was measured with an ELISA reader.

50, 100 and 500 μM of uranyl acetate;

0-1000µM U



High accuracy (mathematical measurement)

Medium Precision

Cell Respiration Assay

Measuring cellular oxygen consumption and uptake

(Belyaeva et al., 2012)
Cell respiration is determined polarographically with the help of a Clark oxygen electrode in a thermostatic water-jacketed vessel with magnetic stirring at 37°C. PC12 cells (107 cells) were incubated in 10 mL of the complete DMEM medium (with serum) in Petri dishes for different lengths of time with various concentrations of the corresponding heavy metal, then collected by centrifugation and transferred to the DMEM medium without serum.

10, 50, 100, or 500 μM



Medium accuracy (estimated spectrophotometrically)

Luciferin-luciferase assay (ATP determination)

Measuring ATP content of the cell

(Li et al., 2003)

For ATP measurement, a commercially available

luciferin-luciferase assay kit was used. Briefly, HL-60 cells were treated with various concentrations of rotenone for 24 h and then collected. After a single wash with ice-cold PBS, cells were lysed with the somatic cell ATP-releasing reagent provided by the kit. Luciferin substrate and luciferase enzyme were

added and bioluminescence was assessed on a spectroflurometer. Whole-cell ATP content was determined by running an internal standard.
0-1000nM of rotenone



High accuracy and precision

Cytochrome c binding domain determination

Measuring identification of the inhibitory site of Cd in CIII

(Wang et al., 2004)

Cytochrome c binding domain determination was

performed in 2 ml of an assay mixture containing 30

mM phosphate, 100 mM KCl, 2 mM KCN, and

0.1% DM, pH 7.0. The final concentration of the

electron donor DBH2 ranged from 20 to 400 µM.

The final concentration of the mitochondrial protein was 13.7 mg/ml. The reaction was started with addition of cytochrome c. DBH2 binding determination was done in the same reaction system as described above. The final concentration of DBH2 was 20 µM. The reaction was started with

addition of DBH2.
5-40µM Cytochrome c



High accuracy and precision

Enzyme Activity Determination

(Kruiderig et al., 1997)
Enzymatic activities of the complexes I to IV were determined by dual wavelength spectrophotometry with an Aminco Dual Wavelength 2 ATM UV-VIS spectrophotometer (Silver Spring, MD). All concentrations below are final concentrations. Complex I (NADH:ubiquinone oxidoreductase) activity was determined at 340 nm with 380 nm as reference wavelength, with a slit width of 3.0 nm according to Estornell et al. (1993). The assay was performed with 10 to 30 mg protein in a final volume of 1 ml of buffer, pH 7.4, containing 10 mM Tris-HCl, 50 mM KCl, 1 mM EDTA and 2 mM KCN. After addition of 75 ml of 1 mM NADH and stabilization of the signal, the reaction was started by addition of 100 ml of 1 mM ubiquinone-10. The activity was calculated from the rate of decrease of NADH (e 5 5.5 mM21 cm21) per mg protein. Complex II (succinate dehydrogenase) activity was determined by the difference in absorbency between 270 and 330 nm according to Estornell et al. (1993). The assay was performed with 10 to 30 mg protein in a final volume of 1 ml of 50 mM potassium phosphate buffer, pH 7.4, containing 100 mM EDTA, 1 mM KCN and 0.1% (w/v) BSA. After addition of 80 ml of 1 mM ubiquinone-0 and stabilization of the signal, the reaction was started by addition of 100 ml of 0.1 M sodium succinate. The activity was calculated from the rate of decrease in ubiquinone (e 5 9.6 mM21 cm21). Complex III (Ubiquinol-cytochrome c reductase) activity was determined by the difference in absorbency between 550 and 580 nm according to Birch-Machin et al. (1993b). The assay was performed with 10 to 30 mg protein in a final volume of 1 ml of 25 mM potassium phosphate buffer, pH 7.2, containing 5 mM MgCl2, 2 mM KCN, 2.5 mg/ml BSA, 2 mg/ml rotenone and 0.5 mM N-D-maltoside. After addition of 10 ml of 3.5 mM ubiquinol and stabilization of the signal, the reaction was started by the addition of 10 ml of 1.5 mM cytochrome cIII. The activity was calculated from the rate of reduction of cytochrome cIII (e 5 19 mM21 cm21). Complex IV (cytochrome c oxidase) activity was determined by the 640 Kruidering et al. Vol. 280 Downloaded from at ASPET Journals on June 28, 2019 difference in absorbency between 550 and 580 nm according to BirchMachin et al. (1993a). The assay was performed with 10 to 30 mg protein in a final volume of 1 ml of 25 mM potassium phosphate buffer, pH 7.0, containing 0.5 mM N-D-maltoside. After addition of 10 ml of 1.5 mM cytochrome cII and stabilization of the signal, the reaction was started by the addition of 10 to 30 mg cells. The activity was calculated from the rate of increase in absorbency caused by oxidation of cytochrome cII to cytochrome cIII (e 5 19 mM21 cm21). All activities were expressed per microgram of protein, which was determined according to Lowry et al. (1951)”    

Domain of Applicability

This free text section should be used to elaborate on the scientific basis for the indicated domains of applicability and the WoE calls (if provided). While structured terms may be selected to define the taxonomic, life stage and sex applicability (see structured applicability terms, above) of the KE, the structured terms may not adequately reflect or capture the overall biological applicability domain (particularly with regard to taxa). Likewise, the structured terms do not provide an explanation or rationale for the selection. The free-text section on evidence for taxonomic, life stage, and sex applicability can be used to elaborate on why the specific structured terms were selected, and provide supporting references and background information.  More help

The inhibition of mitochondrial electron transport chain can occur in any eukaryotic cell.

Evidence for Perturbation by Stressor

Overview for Molecular Initiating Event

When a specific MIE can be defined (i.e., the molecular target and nature of interaction is known), in addition to describing the biological state associated with the MIE, how it can be measured, and its taxonomic, life stage, and sex applicability, it is useful to list stressors known to trigger the MIE and provide evidence supporting that initiation. This will often be a list of prototypical compounds demonstrated to interact with the target molecule in the manner detailed in the MIE description to initiate a given pathway (e.g., 2,3,7,8-TCDD as a prototypical AhR agonist; 17α-ethynyl estradiol as a prototypical ER agonist). Depending on the information available, this could also refer to chemical categories (i.e., groups of chemicals with defined structural features known to trigger the MIE). Known stressors should be included in the MIE description, but it is not expected to include a comprehensive list. Rather initially, stressors identified will be exemplary and the stressor list will be expanded over time. For more information on MIE, please see pages 32-33 in the User Handbook.


Rotenone acts as a mitochondrial respiratory chain complex I inhibitor, and its mechanism for mitochondrial toxicity is through induction of mitochondrial complex I substrate-supported mitochondrial ROS production, leading to a general decrease in ATP synthesis (Li et al., 2003). By inhibiting complex I, rotenone increases the formation of semiubiquinone, which is the primary electron donor in mitochondrial superoxide generation.

Li et al. (2003) demonstrated that rotenone impaired electron transport chain function through measurement of respiration and cellular ATP level of HL-60 cells. At rotenone levels as low as 10nM, as well as at 500nM, cell respiration was inhibited by over 96%. Increasing concentrations of rotenone below 100nM resulted in a sharp decrease of cellular ATP levels, and at 500nM, rotenone decreased cellular ATP level to 64% of control. Mitochondria treated with 200nM of rotenone showed significant levels of ROS production.


Mitochondrial electron transport chain impairment by cadmium occurs through its binding or its transport through the selectively permeable inner mitochondrial membrane to harm structures involved in oxidative phosphorylation (Adiele et al., 2012). Specifically, Wang et al. (2004) showed that CIII inhibition by cadmium is not related to the binding of Cd to the substrate binding sites, but rather to it binding allosterically to the Qo site of CIII. The binding of Cd prevents electron delivery from semiubiquinone to heme b566 and promotes the accumulation of semiubiquinone at the Qo site. The accumulated semiubiquinone is unstable and prone to donation of electrons to molecular oxygen, thus forming superoxide anion (Wang et al., 2004).

Cd-dependent inhibition of CIII was determined in the presence of excess zinc, which has been shown to bind to the Qo site of CIII and inhibit electron transfer activity (Wang et al., 2004). Double reciprocal plots for Zn inhibition of cytochrome c reductase (CIII) activity in the absence and presence of Cd showed that the Vmax values were not changed, indicating competition between Cd and Zn for the same binding site in CIII (Qo) (Wang et al., 2004).

Wang et al. (2004) measured the effects of Cd on the enzyme activity of CIII in the mitochondria of liver, brain, and heart, and determined that maximum inhibition was 30-77%. Adiele et al. (2012) found a maximum of 65% inhibition of CIII enzyme activity by Cd during state 3 mitochondrial respiration, and 75% inhibition of ATP production by Cd compared to the control in rainbow trout liver mitochondria.


Yu et al. (2021) found that uranyl nitrate solution was capable of inhibiting electron transport chain complexes within a HK-2 cell line. This article shows inhibition of complex IV and ATP synthase at very low concentrations (>1 µM and <0.1 µM) (Yu et al., 2021). The IC50 values of complex IV and V were determined to be 3.8 mM (0.9 mg/L) and 4.8 (1.1 mg/L), respectively (Yu et al., 2021), from which it can be inferred that uranium exposure is more toxic to CIV than CV. However, within this experiment none of the other complexes were inhibited, despite the much higher concentrations being used for the treatment (50, 100, 250, and 500 µM) (Yu et al., 2021).


In Miyayama et al.’s (2013) study on the impact of silver treatment on rat livers they found silver dose-dependant inhibition of electron transport chain complexes at low concentrations. Complexes I to IV all showed inhibition, with CIII showing the most inhibition, followed by CI, CIV, and complex II when treated with 0.01, 0.1, 1.0, and 10 µM, respectively (Miyayama et al., 2013). 

Gold nanoparticles

Ferreira et al. (2015) found that rat kidney mitochondria treated with varied sizes of gold nanoparticles (GNPs-10 and GNPs-30) had some complex inhibition as well as some complex activation. Acute exposure to GNPs-30 resulted in the inhibition of CIII, whereas GNPs-10 were able to significantly inhibit complex I activity (Ferreira et al., 2015). Chronic exposure to the GNPs-10 resulted in CII inhibition, while both GNPs-10 and 30 caused CII and CII-III activation when chronically exposed (Ferreira et al., 2015). The activation of CII and CII-III by GNPs-30 were likely a compensation mechanism for decreased activity from CIV (Ferreira et al., 2015). 


In Ma et al.’s (2017) study on the effects of lead on rat liver mitochondria, they found significant dose-dependant inhibition of all four complexes. They found that CIII was the most inhibited complex, followed by CII (Ma et al., 2017). CI and CIV had very minimal inhibition when using 10, 20, 40, and 80 µM doses (Ma et al., 2017). It was suggested that the high level of ETC complex impairment induced by lead was a result of increased electron leakage which resulted in increased ROS generation, and would eventually trigger mitochondrial dysfunction (Ma et al., 2017).


Prakash, Soni, and Kumar (2015) measured the level of inhibition of mitochondrial electron transport chain complexes in rat brains after exposure to sodium arsenite in their drinking water for 12 weeks. They found that CII (32%), CIV (35%), and CI (42%) were all significantly inhibited (Prakash, Soni, and Kumar, 2015).


García-Niño et al. (2013) investigated the effects of chromium treatment on mitochondria from rat liver. Their results showed that chromium treatment significantly inhibited complex I activity when compared to the control (García-Niño et al., 2013).

Other heavy metals

Belyaeva et al. (2012) measured basal, resting, and uncoupled respiration rates in the mitochondria after different times of exposure to mercury, cadmium, and copper. They demonstrated a complete inhibition of respiration after 3 hours of incubation with 50µM Hg2+ or 500µM Cd2+, and 50% inhibition of respiration after 48 hours of exposure to 500µM Cu2+ (Belyavea et al., 2012). All three measurements of respiration rates were strongly decreased, indicating a potent inhibitory effect on the respiratory chain (Belyaeva et al., 2012).


In Santos et al.’s (2007) study on the nephrotoxicity induced by platinum-based cisplatin, ATP synthesis was assessed by measuringkidney ATP content, and was found to be significantly decreased in the cisplatin-treated group (75% of control). They also demonstrated a decrease in mitochondrial lipid levels due to their oxidation by cisplatin, which further inhibited the mitochondrial electron transport chain. Cardiolipin levels in particular were decreased to 73% of the control group (Santos et al., 2007).


List of the literature that was cited for this KE description. Ideally, the list of references, should conform, to the extent possible, with the OECD Style Guide ( (OECD, 2015). More help

Adiele, R. C., Stevens, D., & Kamunde, C. (2012). Differential inhibition of electron transport chain enzyme complexes by cadmium and calcium in isolated rainbow trout (oncorhynchus mykiss) hepatic mitochondria. Toxicological Sciences, 127(1), 110-119. doi:10.1093/toxsci/kfs091

Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., & Walter, P. (2014). Molecular biology of the cell. New York: Garland Science. Retrieved from

Belyaeva, E. A., Sokolova, T. V., Emelyanova, L. V., & Zakharova, I. O. (2012). Mitochondrial electron transport chain in heavy metal-induced neurotoxicity : Effects of cadmium , mercury , and copper. Thescientificworld, 2012, 1-14. doi:10.1100/2012/136063

Blajszczak, C., & Bonini, M. G. (2017). Mitochondria targeting by environmental stressors : Implications for redox cellular signaling. Toxicology, 391, 84-89. doi:10.1016/j.tox.2017.07.013

Gobe, G., & Crane, D. (2010). Mitochondria, reactive oxygen species and cadmium toxicity in the kidney. Toxicology Letters, 198(1), 49-55. doi:

Li, N., Ragheb, K., Lawler, G., Sturgis, J., Rajwa, B., Melendez, J. A., & Robinson, J. P. (2003). Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. The Journal of Biological Chemistry, 278(10), 8516-8525. doi:M210432200 [pii]

Ma, L., Liu, J., Dong, J., Xiao, Q., Zhao, J., & Jiang, F. (2017). Toxicity of Pb2+ on rat liver mitochondria induced by oxidative stress and mitochondrial permeability transition. Toxicol.Res., 6, 822. doi:10.1039/c7tx00204a

Prakash, C., Soni, M., & Kumar, V. (2015). Biochemical and molecular alterations following arsenic-induced oxidative stress and mitochondrial dysfunction in rat brain. Biol.Trace Elem.Res., 167, 121-129. doi:10.1007/s12011-015-0284-9

Santos, N. A. G., Catão, C. S., Martins, N. M., Curti, C., Bianchi, M. L. P., & Santos, A. C. (2007). Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria. Archives of Toxicology, 81(7), 495-504. doi:10.1007/s00204-006-0173-2

Shaki, F., Hosseini, M. J., Ghazi-Khansari, M., & Pourahmad, J. (2012). Toxicity of depleted uranium on isolated rat kidney mitochondria. Biochimica Et Biophysica Acta - General Subjects, 1820(12), 1940-1950. doi:10.1016/j.bbagen.2012.08.015

Shaki, F., Hosseini, M., Ghazi-Khansari, M., & Pourahmad, J. (2013). Depleted uranium induces disruption of energy homeostasis and oxidative stress in isolated rat brain mitochondria. Metallomics, 5(6), 736-744. doi:10.1039/c3mt00019b

Thiébault, C., Carrière, M., Milgram, S., Simon, A., Avoscan, L., & Gouget, B. (2007). Uranium induces apoptosis and is genotoxic to normal rat kidney (NRK-52E) proximal cells. Toxicological Sciences : An Official Journal of the Society of Toxicology, 98(2), 479-487. doi:kfm130 [pii]

Wang, Y., Fang, J., Leonard, S. S., & Krishna Rao, K. M. (2004). Cadmium inhibits the electron transfer chain and induces reactive oxygen species. Free Radical Biology and Medicine, 36(11), 1434-1443. doi:10.1016/j.freeradbiomed.2004.03.010

Yu, L., Li, W., Chu, J., Chen, C., Li, X., Tang, W., . . . Xiong, Z. (2021). Uranium inhibits mammalian mitochondrial cytochrome c oxidase and ATP synthase. Environmental Pollution, 271, 116377. doi:10.1016/j.envpol.2020.116377

Zhao, R., Jiang, S., Zhang, L., & Yu, Z. (2019). Mitochondrial electron transport chain, ROS generation and uncoupling (review). International Journal of Molecular Medicine, 44(1), 3-15. doi:10.3892/ijmm.2019.4188